CMPX logo

Compass Therapeutics, Inc. (CMPX)

Profile

Full Name

Compass Therapeutics, Inc.

Ticker

NASDAQ: CMPX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

April 5, 2021

Indexes

Not included

Website

https://www.compasstherapeutics.com

Employees

35

Key Details

Price

$3.82(2.14%)

Market Cap

$655.41M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$850.00K(100.00% YoY)

Annual EPS

-$0.36(-7.44% YoY)

PE Ratio

-

Next earnings date

Nov 11, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.82
    CMPX price is $3.82

    30-Day Relative Volume

    1.13
    CMPX 30-day relative volume is 1.13

    Price Performance

    Price 1-Day Change

    +2.14%
    CMPX price is up +2.14% today

    Price YTD Change

    +163.45%
    CMPX price is up +163.45% since January 1st

    Price 1-Year Change

    +124.71%
    CMPX price is up +124.71% year-on-year

    Price 3-Year Change

    -4.5%
    CMPX price is down -4.5% over the past 3 years

    Price Range

    Price All-Time High

    $11.00
    CMPX price is currently -65.27% below its historical high of $11.00

    Price 3-Year Low

    $0.77
    CMPX price is currently +399.35% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $655.41M
    CMPX market cap is $655.41 million

    Market Cap 3-Year Change

    +30.01%
    CMPX market cap is up +30.01% over the past 3 years

    Market Cap All-Time High

    $818.40M
    CMPX market cap is currently -19.92% below its historical high of $818.40 million

    Market Cap Sector Percentile

    65.78%
    CMPX market cap is higher than 65.78% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +24.7%
    CMPX shares outstanding is up +24.7% year-on-year

    Shares Outstanding 3-Year Change

    +69.82%
    CMPX shares outstanding is up +69.82% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.50
    CMPX beta is 1.50

    200-day SMA

    $2.83
    CMPX price is currently +34.84% above its 200-day simple moving average

    50-day SMA

    $3.72
    CMPX price is currently +2.73% above its 50-day simple moving average

    14-Day RSI

    45.58
    CMPX 14-day relative strength index is 45.58

    Volume

    1.13
    CMPX 30-day relative volume is 1.13

    ATR

    $0.27
    CMPX average true range is $0.27

    10-day Historical Volatility

    58.17%
    CMPX 10-day historical volatility is 58.17%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $850.00K
    CMPX annual revenue is $850.00 thousand

    Revenue Analysts Estimate

    -
    CMPX annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    +100%
    CMPX annual revenue is up +100% year-on-year

    Revenue Sector Percentile

    36.61%
    CMPX annual revenue is higher than 36.61% of companies in Healthcare sector

    EPS

    EPS

    -$0.36
    CMPX annual earnings per share is -$0.36

    EPS Analysts Estimate

    -$0.52
    CMPX annual earnings per share is currently +30.72% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -7.44%
    CMPX annual earnings per share is down -7.44% year-on-year

    EPS Sector Percentile

    70.98%
    CMPX annual earnings per share is higher than 70.98% of companies in Healthcare sector

    Profit

    Gross Profit

    -$903.00K
    CMPX annual gross profit is -$903.00 thousand

    Gross Margin

    -106.24%
    CMPX annual gross profit margin is -106.24%

    Operating Profit

    -$56.63M
    CMPX annual operating income is -$56.63 million

    Operating Margin

    -6661.76%
    CMPX annual operating profit margin is -6661.76%

    Net Income

    -$49.38M
    CMPX annual net profit is -$49.38 million

    Net Margin

    -5808.82%
    CMPX annual net profit margin is -5808.82%

    Expenses

    Total Expenses

    $57.48M
    CMPX annual total expenses is $57.48 million

    Operating Expenses

    $57.48M
    CMPX annual total operating expenses is $57.48 million

    Cost Of Goods Sold

    $1.75M
    CMPX annual cost of goods sold is $1.75 million

    Selling, General & Administrative Expenses

    $15.13M
    CMPX annual SG&A is $15.13 million

    Depreciation & Amortization

    $1.75M
    CMPX annual D&A is $1.75 million

    Interest Expense

    $0.00
    CMPX annual interest expense is $0.00

    Income Tax

    $0.00
    CMPX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$56.63M
    CMPX annual earnings before interest & taxes is -$56.63 million

    EBITDA

    -$54.87M
    CMPX annual EBITDA is -$54.87 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $140.40M
    CMPX annual total assets is $140.40 million

    Non Current Assets

    $7.65M
    CMPX annual long term assets is $7.65 million

    Current Assets

    $132.75M
    CMPX annual total current assets is $132.75 million

    Cash and Cash Equivalents

    $43.48M
    CMPX annual cash & cash equivalents is $43.48 million

    Accounts Receivable

    -
    CMPX annual accounts receivable value is unknown

    Inventory

    $0.00
    CMPX annual inventory is $0.00

    Liabilities

    Total Liabilities

    $15.17M
    CMPX annual total liabilities is $15.17 million

    Long Term Liabilities

    $6.30M
    CMPX annual total long term liabilities is $6.30 million

    Current Liabilities

    $8.87M
    CMPX annual current liabilities is $8.87 million

    Accounts Payable

    $2.25M
    CMPX annual accounts payable is $2.25 million

    Debt

    Total Debt

    $6.63M
    CMPX annual total debt is $6.63 million

    Total Debt 1-Year Change

    +282.8%
    CMPX annual total debt is up +282.8% year-on-year

    Long Term Debt

    $6.30M
    CMPX annual long term debt is $6.30 million

    Short Term Debt

    $338.00K
    CMPX annual short term debt is $338.00 thousand

    Equity & Capital

    Shareholders Equity

    $125.23M
    CMPX annual stockholders equity is $125.23 million

    Book Value

    $125.23M
    CMPX annual book value is $125.23 million

    Retained Earnings

    -$364.68M
    CMPX annual retained earnings is -$364.68 million

    Working Capital

    $123.88M
    CMPX annual working capital is $123.88 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$44.85M
    CMPX annual cash from operations is -$44.85 million

    Cash From Operations 1-Year Change

    -10.43%
    CMPX annual cash from operations is down -10.43% year-on-year

    Cash From Investing

    $46.77M
    CMPX annual cash from investing is $46.77 million

    Cash From Investing 1-Year Change

    +73.45%
    CMPX annual cash from investing is up +73.45% year-on-year

    Cash From Financing

    $17.34M
    CMPX annual cash from financing is $17.34 million

    Cash From Financing 1-Year Change

    +490.73%
    CMPX annual cash from financing is up +490.73% year-on-year

    CAPEX

    CAPEX

    $44.00K
    CMPX annual capital expenditures is $44.00 thousand

    CAPEX 1-Year Change

    +46.67%
    CMPX annual capital expenditures is up +46.67% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$44.90M
    CMPX annual free cash flow is -$44.90 million

    Free Cash Flow 1-Year Change

    -10.46%
    CMPX annual free cash flow is down -10.46% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -106.24%
    CMPX annual gross profit margin is -106.24%

    Operating Margin

    -6661.76%
    CMPX annual operating profit margin is -6661.76%

    Net Margin

    -5808.82%
    CMPX annual net profit margin is -5808.82%

    ROA & ROE

    ROA

    -33.22%
    CMPX annual return on assets is -33.22%

    ROE

    -36.07%
    CMPX annual return on equity is -36.07%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    CMPX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    CMPX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    7.03
    CMPX price to book ratio is 7.03

    PB Ratio Sector Percentile

    83.47%
    CMPX price to book ratio is higher than 83.47% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    CMPX price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    CMPX price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $564.36M
    CMPX enterprise value is $564.36 million

    Enterprise Value Sector Percentile

    66.02%
    CMPX enterprise value is higher than 66.02% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -8.51
    CMPX EV/EBITDA is -8.51

    EV/EBITDA Sector Percentile

    16.11%
    CMPX EV/EBITDA is higher than 16.11% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    14.96
    CMPX annual current ratio is 14.96

    Quick Ratio

    14.96
    CMPX annual quick ratio is 14.96

    Leverage

    Debt To Equity

    0.05
    CMPX annual debt to equity ratio is 0.05

    Interest Coverage Ratio

    -
    CMPX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    CMPX piotroski f-score value is unknown

    Altman Z-Score

    22.02
    CMPX altman z-score is 22.02

    Analyst ratings

    Recent major analysts updates

    Oct 6, 25 LifeSci Capital
    Outperform
    Aug 12, 25 Guggenheim
    Buy
    Aug 12, 25 D. Boral Capital
    Buy
    May 9, 25 Guggenheim
    Buy
    Apr 28, 25 D. Boral Capital
    Buy
    Apr 22, 25 Guggenheim
    Buy
    Apr 21, 25 HC Wainwright & Co.
    Buy
    Apr 21, 25 D. Boral Capital
    Buy
    Apr 4, 25 HC Wainwright & Co.
    Buy
    Apr 2, 25 Leerink Partners
    Outperform

    Institutional Ownership

    Screeners with CMPX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Compass Therapeutics, Inc.?
    • Does Compass Therapeutics, Inc. pay dividends?
    • What sector is Compass Therapeutics, Inc. in?
    • What industry is Compass Therapeutics, Inc. in?
    • What country is Compass Therapeutics, Inc. based in?
    • When did Compass Therapeutics, Inc. go public?
    • Is Compass Therapeutics, Inc. in the S&P 500?
    • Is Compass Therapeutics, Inc. in the NASDAQ 100?
    • Is Compass Therapeutics, Inc. in the Dow Jones?
    • When was Compass Therapeutics, Inc.'s last earnings report?
    • When does Compass Therapeutics, Inc. report earnings?

    What is the ticker symbol for Compass Therapeutics, Inc.?

    The ticker symbol for Compass Therapeutics, Inc. is NASDAQ:CMPX

    Does Compass Therapeutics, Inc. pay dividends?

    No, Compass Therapeutics, Inc. does not pay dividends

    What sector is Compass Therapeutics, Inc. in?

    Compass Therapeutics, Inc. is in the Healthcare sector

    What industry is Compass Therapeutics, Inc. in?

    Compass Therapeutics, Inc. is in the Biotechnology industry

    What country is Compass Therapeutics, Inc. based in?

    Compass Therapeutics, Inc. is headquartered in United States

    When did Compass Therapeutics, Inc. go public?

    Compass Therapeutics, Inc.'s initial public offering (IPO) was on April 5, 2021

    Is Compass Therapeutics, Inc. in the S&P 500?

    No, Compass Therapeutics, Inc. is not included in the S&P 500 index

    Is Compass Therapeutics, Inc. in the NASDAQ 100?

    No, Compass Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Compass Therapeutics, Inc. in the Dow Jones?

    No, Compass Therapeutics, Inc. is not included in the Dow Jones index

    When was Compass Therapeutics, Inc.'s last earnings report?

    Compass Therapeutics, Inc.'s most recent earnings report was on August 11, 2025

    When does Compass Therapeutics, Inc. report earnings?

    The next expected earnings date for Compass Therapeutics, Inc. is November 11, 2025
    On this page